Terns Pharmaceuticals, Inc. TERN 深 沪
交易中 03-25 11:44:20 美东时间
52.755
+2.755
+5.51%
华盛通- 最 高52.79
- 今 开52.61
- 成交量 6091.37万股
- 最 低 52.59
- 昨 收 50.00
- 总市值 57.38亿
- 52周最高 52.79
- 市盈率 静 --
- 换手率 56.00%
- 52周最低 1.865
- 委 比 -24.22%
- 总股本 1.09亿
- 历史最高 52.79
- 量 比 56.12
- 振 幅 0.40%
- 历史最低 1.45
- 每 手 1
- 风险率 16.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多HC Wainwright & Co. Downgrades Terns Pharma to Neutral, Lowers Price Target to $53
HC Wainwright & Co. analyst Andres Y. Maldonado downgrades Terns Pharma (NASDAQ:TERN) from Buy to Neutral and lowers the price target from $60 to $53.
43分钟前
Merck Nears $6 Billion Deal To Buy Terns Pharma: Report
Merck is reportedly nearing a $6 billion acquisition of Terns Pharmaceuticals to strengthen its oncology pipeline ahead of Keytruda's patent expiry.
今天 17:38
美股夜盘 | Blaize Holdings, Inc.涨55.86%，Next Technology涨28.00%
Blaize Holdings, Inc.涨55.86%；Next Technology涨28.00%；Braze, Inc. Class A涨20.09%
今天 10:04
美股夜盘 | Terns Pharmaceuticals, Inc.涨10.00%，最新股价55.0美元
Terns Pharmaceuticals, Inc.涨10.00%，报55.0美元
今天 09:01
期权扫描 | 裁员20%+新模型难产，Meta看涨期权占比仍超六成；美光绩前期权成交活跃
裁员20%+新模型难产，Meta看涨期权占比仍超六成；获Wedbush上调目标价至500美元，美光绩前期权成交活跃>>
03-16 19:20
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
Terns Pharmaceuticals granted equity inducement awards to two new employees under the 2022 Employment Inducement Award Plan. The awards, totaling options for 312,000 shares of common stock with a $40.40 exercise price, vest over four years. The stock options were approved by the Compensation Committee and comply with Nasdaq Listing Rule 5635(c)(4). Terns is a clinical-stage oncology company focused on innovative cancer treatments.
01-02 21:05
美股周涨跌榜 | “减肥神药”临床数据引爆！WaVe生命科学周涨121%；太空概念股Planet Labs周涨42.8%
“减肥神药”临床数据引爆！WaVe生命科学周涨121%；福尼克斯周内飙升50%，创历史新高；SpaceX上市传闻引爆市场，太空概念股Planet Labs周涨42.8%>>
2025-12-13 10:07
美股大行评级 | 绩后分化！甲骨文遭14家大行集体下调目标价；新思科技、Planet获多家机构上调目标价！
今日重点评级关注：HC Wainwright & Co.：维持Moleculin Biotech"买入"评级，目标价从4美元升至22美元；HC Wainwright & Co.：上调Soluna Holdings评级至"买入"，目标价5美元
2025-12-12 10:24
Terns Pharmaceutical prices stock at $40 per share
Terns Pharmaceuticals (TERN) priced an upsized underwritten public offering of 16.25M shares at a public offering price of $40.00 per share. The gross proceeds from the offering are expected to be $65...
2025-12-10 15:20
美股大行评级 | 花旗上调苹果目标价升至330美元；GPCR、KYMR、MAMA、TERN、WVE等获多家机构上调目标价
今日重点评级关注：Chardan Capital：维持Senti Biosciences"买入"评级，目标价从12美元升至13美元；Guggenheim：维持Praxis Precision Medicine"买入"评级，目标价从540美元升至760美元
2025-12-10 10:33
